PLRZ
Polyrizon Ltd (PLRZ)
Healthcare • NASDAQ • $16.34+15.56%
- Symbol
- PLRZ
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $16.34
- Daily Change
- +15.56%
- Market Cap
- $30.59M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $628.50
- 52W Low
- $2.88
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Company websiteResearch PLRZ on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.